Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/4821
Title: Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management
Other Titles: Meme Kanseri Yönetiminde COVID-19 Aşısına Bağlı Hipermetabolik Aksiller Lenf Nodları
Authors: Taşçı, Cengiz
Dirican, Ahmet
Sözbilen, Ethem Murat
Pehlivan, F.S.
Serter, Selim
Keywords: 18F-FDG PET/CT
Axillary lymph nodes
breast cancer
COVID-19 vaccination
CD20 antigen
CD3 antigen
fluorodeoxyglucose f 18
tozinameran
adjuvant chemotherapy
adult
Article
axillary lymph node
cancer radiotherapy
cancer staging
case report
clinical article
coronavirus disease 2019
female
human
human tissue
hypermetabolism
invasive ductal breast carcinoma
lymph node metastasis
lymphadenopathy
lymphoid tissue
maximum standardized uptake value
neoadjuvant chemotherapy
positron emission tomography-computed tomography
primary tumor
simple mastectomy
treatment response
tumor volume
vaccination
Publisher: Galenos Publishing House
Abstract: A 42-year-old female patient diagnosed with invasive ductal breast ca underwent18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) scan for staging, 1.5 cm diameter hypermetabolic lesion was observed in the lower inner quadrant of the right breast that was compatible with primary tumor [maximum standardized uptake value (SUVmax ): 10.5]. No pathological18F-FDG uptake was observed in lymph nodes whose fatty hilum was seen in the right axilla. However, in the left axilla and left deep axilla, hypermetabolic lymph nodes with a maksimum diameter of 19 mm and fatty hilum were observed (SUVmax: 8.0). In a detailed CT evaluation, these lymph nodes have thicker walls than the ones in the right axilla. The patient was questioned again and coronavirus disease-2019 (COVID-19) vaccination history (with BNT162b2, COVID-19 mRNA vaccine) was determined that was administrated to the left arm 5 days ago. Tru-cut biopsy was performed from the left aksillary lymph nodes and proved to be reactive lymphoid tissue and there was no primary or metastatic tumor in these axillary lymph node tissues. The patient was given neoadjuvant chemotherapy 4.5 months after the first18F-FDG PET/CT, and the second was performed for the treatment response evaluation. Significant regression was determined from the findings. The patient underwent right total mastechtomy. She was being followed up with adjuvant chemotherapy and radiotherapy. In conclusion, hypermetabolic lymph nodes in the axillas should be interrogated for vaccination in patients with breast cancer. Hypermetabolic lymph nodes observed on the same side of the vaccinated arm in the 18 F-FDG PET/CT scan may be related to vaccine-induced reactive lymph node enlargement. Lymph node metastasis may be excluded, especially if there are hypermetabolic lymph nodes with preserved fatty hilum in the contralateral axilla on the same side as the vaccinated arm. Active lymph nodes reactive to the vaccine become inactive after a while. © 2023 by the Turkish Society of Nuclear Medicine.
URI: https://doi.org/10.4274/mirt.galenos.2023.82712
https://hdl.handle.net/20.500.14365/4821
ISSN: 2146-1414
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection

Files in This Item:
File SizeFormat 
MIRT-32-181-En.pdf807.67 kBAdobe PDFView/Open
Show full item record



CORE Recommender

Page view(s)

100
checked on Nov 18, 2024

Download(s)

12
checked on Nov 18, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.